MENU
+Compare
KOD
Stock ticker: NASDAQ
AS OF
Aug 26, 10:31 AM (EDT)
Price
$9.56
Change
+$0.09 (+0.95%)
Capitalization
500.22M

KOD Kodiak Sciences Forecast, Technical & Fundamental Analysis

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases... Show more

Industry: #Biotechnology
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KOD with price predictions
Aug 25, 2025

Aroon Indicator for KOD shows an upward move is likely

KOD's Aroon Indicator triggered a bullish signal on August 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 245 similar instances where the Aroon Indicator showed a similar pattern. In of the 245 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on KOD as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for KOD moved above the 200-day moving average on August 13, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KOD advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KOD moved out of overbought territory on August 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where KOD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KOD turned negative on August 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KOD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KOD broke above its upper Bollinger Band on August 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KOD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.117) is normal, around the industry mean (19.083). P/E Ratio (0.000) is within average values for comparable stocks, (54.504). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.646). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (304.949).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KOD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

KOD is expected to report earnings to rise 2.91% to -105 cents per share on November 12

Kodiak Sciences KOD Stock Earnings Reports
Q3'25
Est.
$-1.06
Q2'25
Beat
by $0.01
Q1'25
Beat
by $2.14
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.06
The last earnings report on August 13 showed earnings per share of -102 cents, beating the estimate of -103 cents. With 12.56K shares outstanding, the current market capitalization sits at 500.22M.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of retinal disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1200 Page Mill Road
Phone
+1 650 281-0850
Employees
111
Web
https://www.kodiak.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FERIX62.38N/A
N/A
Fidelity Advisor Emerging Asia I
TEOIX10.00N/A
N/A
Transamerica Emerging Markets Eq I
JHQDX19.27N/A
N/A
JPMorgan Hedged Equity 2 I
UIVRX13.08N/A
N/A
MFS Intrinsic Value R6
CFSSX12.18N/A
N/A
Column Small Cap Select

KOD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-7.16%
XNCR - KOD
50%
Loosely correlated
-4.76%
MGNX - KOD
46%
Loosely correlated
-2.96%
IDYA - KOD
45%
Loosely correlated
-1.63%
BEAM - KOD
43%
Loosely correlated
-1.20%
NRIX - KOD
43%
Loosely correlated
-4.64%
More